- 2019.09.20
(109KB) - Notification of approval for manufacturing and marketing approval of HARUROPI® TAPE in Japan (Transdermal, Parkinson's disease treatment patch, development code: HP-3000)
- 2019.08.29(105KB)
- Notification of application for manufacturing and marketing approval of the additional indications of opioid analgesic naive cancer pain relief of FENTOS® TAPE (Transdermal, pain management patch,Development code: HFT-290) in Japan
- 2019.07.10
- FY02/2020 Q1 Results Earnings Release Presentation
- 2019.06.03( 51KB)
- Notification of Transfer of Marketing and Manufacturing Approval and Distribution Rights for the transdermal follicle and luteinizing hormone product "Menoaid® Combipatch"
- 2019.05.24( 85KB)
- Notification of the results of the Phase II clinical study of HP-5070 in Japan (a transdermal drug for the treatment of primary local hyperhidrosis)
- 2019.05.24( 85KB)
- Notification of the results of Phase III clinical study of HP-3150 in Japan for "cancer pain" (an analgesic transdermal drug containing NSAIDs)